摘要
目的通过评价《现代中医药》近5年RCT文献的质量,为今后期刊的RCT文献质量提升提供参考。方法依据CONSORT 2025版30项内容42个条目建立量化评价表格,对《现代中医药》2020年1月—2025年7月发表的RCT文献进行资料提取和记录,计算每个条目所满足的论文篇数及其所占百分率。结果《现代中医药》近5年共发表临床研究文章309篇,其中RCT文献265篇。报告率为100%的条目共16条,报告率>50%的条目2条,报告率<50%的条目9条,报告率为0%的条目共15条。结论《现代中医药》近5年RCT文献质量整体较低,尤其在文题、样本量估算、随机序列产生、分配隐藏、盲法、统计方法、临床试验注册等方面普遍存在不足。建议将CONSORT声明、临床试验注册制度引入稿约,引导作者在撰写RCT报告时遵守清单中的条目要求,从而提升期刊的学术质量及影响力。
Objective To evaluate the quality of RCTs published in Modern Chinese Medicine in the past five years and provide references for improving the quality of RCTs in the journal in the future.Methods A quantitative evaluation form was established based on the 30 items and 42 sub-items of the CONSORT 2025 statement.Data were extracted and recorded from RCTs published in Modern Chinese Medicine from January 2020 to July 2025.The number of papers meeting each item and the percentage were calculated.Results A total of 309 clinical research articles were published in Modern Chinese Medicine in the past five years,including 265 RCTs.There were 16 items with a reporting rateof 100%,2 items with a reporting rate>50%,9 items with a reporting rate<50%,and 15 items with a reporting rate of 0%.Conclusion The quality of RCTs published in Modern Chinese Medicine in the past five years was generally low,especially in the aspects of title,sample size estimation,random sequence generation,allocation concealment,blinding,statistical methods,and clinical trial registration.It is suggested that the CONSORT statement and clinical trial registration system be introduced into the author guidelines to guide authors to follow the requirements of the checklist when writing RCT reports,thereby improving the academic quality and influence of the journal.
作者
蒲瑞生
巩振东
宋蓓
刘惠娴
PU Ruisheng;GONG Zhendong;SONG Bei;LIU Huixian(Academic Journal Center,Shaanxi University of Chinese Medicine,Xianyang,Shaanxi 712046,China)
出处
《现代中医药》
2025年第5期173-178,共6页
Modern Chinese Medicine
基金
陕西省科学技术协会科技期刊项目(2023-3-3-1)。
关键词
现代中医药
随机对照临床试验
CONSORT声明
文献质量评价
Modern Chinese Medicine
randomized controlled clinical trial
CONSORT statement
literature quality evaluation
